Russia Respiratory Care Devices Market Overview, 2031

The market for respiratory devices in Russia has progressed as a result of demographic changes such as an aging populace, environmental concerns regarding respiratory health, and strategic policy changes aimed at replacing imports. The medical device market in the country is large yet the proportion of medical devices made domestically is relatively low, accounting for only about 20–31% of the total, highlighting a continued dependency on imports despite the growth of local production capabilities. Specific types of respiratory equipment such as mechanical ventilators, pulse oximeters, and cardiopulmonary resuscitation devices are being increasingly made within Russia in industrial hubs including Moscow, Tyumen, Nizhny Novgorod, and Bashkortostan, propelled by government initiatives aimed at enhancing self-sufficiency. At times, government regulations have prohibited the purchase of certain foreign ventilators for state institutions when domestic versions are available, emphasizing policy measures to stimulate local manufacturing. The segmentation of the market indicates growth across various respiratory sectors. This growth trend is indicative of the heightened adoption of advanced respiratory care technologies in both clinical settings and at home. The prevalence of cold-weather health issues and chronic diseases such as COPD, asthma, and bronchitis within various regions of Russia increases the importance of dependable respiratory devices from ventilators used in urgent care to oxygen concentrators needed for long-term treatment, reinforcing the demand for resilient, locally manufactured equipment designed for extreme conditions and unswerving service. Russia's initiative for import replacement seeks to diminish reliance on foreign products through strategic industrial policies, altering public procurement standards to prioritize Russian and EAEU origin goods and promoting investment in domestic research, development, and production capabilities.

According to the research report, " Russia Respiratory Devices Market Overview, 2031," published by Bonafide Research, the Russia Respiratory Devices market is anticipated to grow at more than 6.23% CAGR from 2026 to 2031. Forecasts for the market of respiratory devices in Russia differ greatly based on category and reporting criteria, yet they generally show consistent growth driven by advancements in healthcare and government efforts. While comprehensive national estimates for all respiratory devices are not as unified, these segments reflect significant growth in protective, diagnostic, and therapeutic respiratory technologies over the next ten years. Recent changes involve a shift towards local supply chains and technological advancements as Russia implements import substitution strategies to alleviate supply issues and enhance healthcare robustness. Domestic companies like NPP Respirator, with their historical know-how in oxygen and respiratory equipment, illustrate the traditional manufacturing strength of Russia that is now being utilized to satisfy local needs and replace foreign imports. State initiatives such as contracts that prioritize domestic manufacturers when suitable Russian alternatives exist and investments in infrastructure signify potential for larger-scale production of ventilators, concentrators, and complementary diagnostic tools. Another factor contributing to growth is the upgrade of healthcare facilities funded by the government, where enhancements to intensive care units and remote care systems boost the need for sophisticated respiratory equipment. While imported high-tech equipment often requiring certification and registration managed by Roszdravnadzor the Russian Federal Service for Surveillance in Healthcare remains significant, regulatory frameworks are changing to ensure a balance between safety, efficiency, and local availability.

Russia Respiratory Devices market by product type is divided into therapeutic devices, monitoring devices, diagnostic devices and consumables and accessories. In Russia, the market for respiratory devices based on product type combines therapeutic, monitoring, diagnostic, and consumable technologies to meet the challenges of increasing respiratory illness cases and the modernization of healthcare services. The therapeutic devices category encompasses essential equipment like ventilators, oxygen concentrators, PAP/CPAP/BiPAP devices, nebulizers, and high-flow therapy machines that assist in the treatment of both obstructive and restrictive lung ailments. The demand in this area has risen due to chronic illnesses and sudden respiratory flare-ups, particularly in aging populations and industrial zones. Local companies and research organizations are increasingly creating and testing ventilators designed for Russian healthcare conditions, including models intended for emergency and intensive care situations. The monitoring devices category includes pulse oximeters, capnographs, and portable or connected surveillance systems used in hospitals, outpatient facilities, and homes. These devices play a crucial role in the constant evaluation of respiratory health, especially concerning COPD, asthma. Digital health initiatives in Russia are accelerating the development of monitoring solutions that facilitate remote data sharing. Diagnostic devices, such as spirometers, peak flow meters, and equipment for sleep studies related to conditions like sleep apnea, constitute a separate category focused on early diagnosis, creating treatment plans, and monitoring disease progression. The growth of outpatient diagnostic capabilities and regional diagnostic centers, supported by national health programs, drives the uptake of these devices. Consumables and accessories, including masks, nebulizer kits, breathing circuits, and filters, form a category with frequent usage in both critical and routine care scenarios.

Russia Respiratory Devices market by end user is divided into hospitals, ambulatory care centers, home care settings and other user. Within Russia’s market for respiratory devices, the end-user segmentation highlights different paths of adoption among hospitals, ambulatory care centres ACCs, home care settings, and other facilities. Hospitals, particularly those that are regional and tertiary, make up the largest portion of respiratory device purchases because of the need for acute care, critical services, and surgeries that require ventilators, advanced oxygen systems, and monitoring tools. Major cities like Moscow and St. Petersburg significantly contribute to the demand for advanced technology devices, backed by modernization efforts as part of national health initiatives. Ambulatory Care Centres, which include specialized respiratory clinics and polyclinics, are increasing their involvement in the early detection and ongoing treatment of chronic illnesses like asthma and COPD. These facilities are adopting more portable spirometers, PAP systems for evaluating sleep apnea, and connected monitoring devices to facilitate outpatient care and decrease hospital visits. Home care settings are becoming a fast-growing area as changing demographics and the rise in chronic diseases push the need for long-term respiratory support outside hospitals. Portable oxygen concentrators, CPAP/BiPAP machines, and home pulse oximeters allow patients with chronic respiratory issues to manage their conditions with fewer trips to the hospital. Market trends show an increase in sales of these devices, which are linked to digital health platforms for remote monitoring, demonstrating the preference of patients for home care when possible. Other end users consist of long-term care facilities, rehabilitation centres, emergency medical services, and mobile health teams, especially significant in extensive rural areas where access to full hospital care is restricted. These environments use a variety of portable ventilators, monitoring devices, and consumables to stabilize patients before they are transferred to hospitals.

"Considered in this report
• Historic Year: 2020
• Base year: 2025
• Estimated year: 2026
• Forecast year: 2031



Aspects covered in this report
• Respiratory Care Devices Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product Type
• Therapeutic Devices (Inhalers,Ventilators,Positive Airway Pressure (PAP) Devices,Humidifiers,Nebulizers,Others(Oxygen Concentrators, oxygen Hood))
• Monitoring Devices (Pulse Oximeters,Gas Analyzers,Others)
• Diagnostic Devices (Spirometers,Polysomnography Devices,Peak Flow Meters,Others)
• Consumables and Accessories (Disposable Resuscitators,Breathing Circuits,Masks,Tracheostomy Tubes,Others(Nasal Cannulas))
By Disease Indication
• Chronic Obstructive Pulmonary disease (COPD)
• Sleep Apnea
• Asthma
• Infectious Diseases
• Other disease Indications (Respiratory Distress Syndrome, cystic Fibrosis)

By End User
• Hospitals
• Ambulatory Care Centers (ACCs)
• Home care Settings
• Other End User
"